USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 8, 2022 | Sep 2022 | - | - | $-0.60 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 8, 2022 | Sep 2022 | - | - | $2.52M |
Htg Molecular Diagnostics, Inc's next earnings date is Tuesday, Nov 8, 2022 for the fiscal quarter ending Sep 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $-2.00 | $-2.54 | $-1.68 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-2.00 | $-2.31 | $-2.33 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 4 | $17.21M | $13.50M | $22.00M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Aug 10, 2022 | Jun 2022 | $-0.60 | - | - |
| May 12, 2022 | Mar 2022 | $-0.71 | $-0.81 | -14.08% |
| Mar 29, 2022 | Dec 2021 | $-0.59 | $-0.69 | -16.95% |
| Nov 10, 2021 | Sep 2021 | $-0.64 | $-0.60 | 6.73% |
| Aug 12, 2021 | Jun 2021 | $-0.77 | $-0.65 | 15.23% |
| May 13, 2021 | Mar 2021 | $-0.98 | $-0.80 | 18.64% |
| Mar 25, 2021 | Dec 2020 | $-1.12 | $-0.91 | 18.51% |
| Nov 10, 2020 | Sep 2020 | $-1.05 | $-1.05 | - |
| Aug 11, 2020 | Jun 2020 | $-1.25 | $-1.18 | 5.32% |
| May 13, 2020 | Mar 2020 | $-1.05 | $-1.20 | -14.29% |
| Mar 25, 2020 | Dec 2019 | $-1.45 | $-0.15 | 89.66% |
| Nov 12, 2019 | Sep 2019 | $-2.48 | $-2.25 | 9.09% |
| Aug 6, 2019 | Jun 2019 | $-2.29 | $-2.55 | -11.48% |
| May 9, 2019 | Mar 2019 | $-2.93 | $-2.85 | 2.56% |
| Mar 7, 2019 | Dec 2018 | $-2.66 | $-1.05 | 60.56% |
| Nov 8, 2018 | Sep 2018 | $-2.85 | $-2.55 | 10.53% |
| Aug 7, 2018 | Jun 2018 | $-3.00 | $-2.10 | 30.00% |
| May 10, 2018 | Mar 2018 | $-3.83 | $-3.20 | 16.27% |
| Mar 22, 2018 | Dec 2017 | $-4.58 | $-2.25 | 50.82% |
| Nov 7, 2017 | Sep 2017 | $-7.80 | $-6.90 | 11.54% |
| Aug 8, 2017 | Jun 2017 | $-8.63 | $-9.00 | -4.35% |
| May 15, 2017 | Mar 2017 | $-10.50 | $-10.95 | -4.29% |
| Mar 23, 2017 | Dec 2016 | $-11.40 | $-11.40 | - |
| Nov 14, 2016 | Sep 2016 | $-12.68 | $-13.80 | -8.88% |
| Aug 9, 2016 | Jun 2016 | $-14.25 | $-14.70 | -3.16% |
| May 12, 2016 | Mar 2016 | $-12.30 | $-15.30 | -24.39% |
| Mar 25, 2016 | Dec 2015 | $-11.93 | $-7.05 | 40.88% |
| Nov 12, 2015 | Sep 2015 | $-0.85 | $-0.76 | 10.59% |
| Aug 6, 2015 | Jun 2015 | $-0.70 | $-1.73 | -147.14% |
| May 6, 2015 | Mar 2015 | - | $-0.73 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 29, 2022 | Dec 2021 | $-2.54 | $-2.74 | - |
| Mar 25, 2021 | Dec 2020 | $-4.80 | $-4.34 | - |
| Mar 25, 2020 | Dec 2019 | $-0.55 | $-7.80 | - |
| Mar 7, 2019 | Dec 2018 | $-0.70 | $-8.90 | - |
| Mar 22, 2018 | Dec 2017 | $-2.03 | $-29.10 | - |
| Mar 23, 2017 | Dec 2016 | - | $-55.20 | - |
| Mar 25, 2016 | Dec 2015 | - | $-10.27 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Aug 10, 2022 | Jun 2022 | - | - | - |
| May 12, 2022 | Mar 2022 | - | $1.18M | - |
| Mar 29, 2022 | Dec 2021 | $2.90M | $2.88M | 0.99% |
| Nov 10, 2021 | Sep 2021 | $2.58M | $2.52M | 0.98% |
| Aug 12, 2021 | Jun 2021 | $2.07M | $2.07M | 1.00% |
| May 13, 2021 | Mar 2021 | $1.69M | $1.44M | 0.85% |
| Mar 25, 2021 | Dec 2020 | $2.32M | $2.58M | 1.11% |
| Nov 10, 2020 | Sep 2020 | $2.23M | $1.78M | 0.80% |
| Aug 11, 2020 | Jun 2020 | $1.79M | $1.96M | 1.10% |
| May 13, 2020 | Mar 2020 | $3.04M | $2.23M | 0.73% |
| Mar 25, 2020 | Dec 2019 | $4.85M | $4.80M | 0.99% |
| Nov 12, 2019 | Sep 2019 | $5.47M | $5.40M | 0.99% |
| Aug 6, 2019 | Jun 2019 | $5.56M | $5.80M | 1.04% |
| May 9, 2019 | Mar 2019 | $2.73M | $3.20M | 1.17% |
| Mar 7, 2019 | Dec 2018 | $8.16M | $7.73M | 0.95% |
| Nov 8, 2018 | Sep 2018 | $5.11M | $4.71M | 0.92% |
| Aug 7, 2018 | Jun 2018 | $5.29M | $4.91M | 0.93% |
| May 10, 2018 | Mar 2018 | $4.97M | $4.16M | 0.84% |
| Mar 22, 2018 | Dec 2017 | $6.98M | $7.90M | 1.13% |
| Nov 7, 2017 | Sep 2017 | - | $3.72M | - |
| Aug 8, 2017 | Jun 2017 | - | $1.76M | - |
| May 15, 2017 | Mar 2017 | - | $1.37M | - |
| Mar 23, 2017 | Dec 2016 | - | $1.46M | - |
| Nov 14, 2016 | Sep 2016 | - | $913.90K | - |
| Aug 9, 2016 | Jun 2016 | - | $1.90M | - |
| May 12, 2016 | Mar 2016 | - | $865.23K | - |
| Mar 25, 2016 | Dec 2015 | - | $1.22M | - |
| Nov 12, 2015 | Sep 2015 | - | $1.01M | - |
| Aug 6, 2015 | Jun 2015 | - | $790.55K | - |
| May 6, 2015 | Mar 2015 | - | $1.02M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 29, 2022 | Dec 2021 | $8.99M | $8.91M | -0.93% |
| Mar 25, 2021 | Dec 2020 | $8.25M | $8.55M | 3.62% |
| Mar 25, 2020 | Dec 2019 | $19.25M | $19.20M | -0.24% |
| Mar 7, 2019 | Dec 2018 | $21.96M | $21.50M | -2.08% |
| Mar 22, 2018 | Dec 2017 | $13.80M | $14.76M | 6.95% |
| Mar 23, 2017 | Dec 2016 | - | $5.13M | - |
| Mar 25, 2016 | Dec 2015 | - | $4.04M | - |
HTGM's next earnings date is Tuesday, Nov 8, 2022 for the fiscal quarter ending Sep 30, 2022.
Htg Molecular Diagnostics, Inc's previous earnings date was Aug 10, 2022 for its fiscal quarter ended Jun 30, 2022.
Htg Molecular Diagnostics, Inc's previous annual earnings date was Mar 29, 2022 for its fiscal year ended Dec 31, 2021.
HTGM's earnings per share (EPS) was $-2.74, missing the consensus analysts forecast of $-2.54 by 7.90% , and higher than the previous year's EPS (Dec 2020) by -36.90%.
Revenues were $8.91M, worse than the forecast of $8.99M by -0.93%, and up by 4.19% from previous year's revenue.
The company reported a net income of $-17.15M.
Htg Molecular Diagnostics, Inc reported a free cash flow of $-17.15M for its fiscal year, compared to $-16.75M a year ago.
The company ended the fiscal year with $16.88M in total debt, an increase of 37.48% compared to the previous year.
